Saturday, June 13, 2026 Sign In Register FREE My Account Help

Explore

Flamenet Tools

Make FlameNet your home page

Science Home

Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109 – PR Newswire

Posted by admin on Tuesday, March 24, 2026 at 12:00 pm — No Comments | Leave a Comment

Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109 PR Newswire

« US issues worldwide travel caution as tensions rise – USA TodayFull-Year Estimates Show Overall Stability in Abortion Incidence, Decreased Travel and Increased Telehealth Provision – Guttmacher Institute »

13 members · 0 new today · 0 online now · 489 posts in last 24h